Evaluation of the E-Psycho-Oncological Short-Term Intervention "By Your Side" to Reduce Cancer-Related Distress: A Pilot Study.

IF 2.8 3区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Integrative Cancer Therapies Pub Date : 2025-01-01 DOI:10.1177/15347354251320047
Sven Erik Strunk, Johanna Graf, Julia Barbara Krakowczyk, Alexandra Wieser, Jana Heinen, Caterina Schug PhD, Lisa Maria Jahre, Eva-Maria Skoda, Yesim Erim, Martin Teufel, Alexander Bäuerle
{"title":"Evaluation of the E-Psycho-Oncological Short-Term Intervention \"By Your Side\" to Reduce Cancer-Related Distress: A Pilot Study.","authors":"Sven Erik Strunk, Johanna Graf, Julia Barbara Krakowczyk, Alexandra Wieser, Jana Heinen, Caterina Schug PhD, Lisa Maria Jahre, Eva-Maria Skoda, Yesim Erim, Martin Teufel, Alexander Bäuerle","doi":"10.1177/15347354251320047","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>A large number of patients with cancer experience distress, but not all of them receive adequate psychological support. The e-psycho-oncological short-term intervention \"By your Side\" was developed to offer evidence-based and low-threshold support for cancer patients dealing with distress.</p><p><strong>Methods: </strong>A longitudinal intervention pilot study was conducted from 4 March 2022 to 4 January 2023. N = 91 participants took part in the study. N = 82 completed the first module, while n = 23 successfully completed the whole intervention and were included in the final data analyses. \"By your Side\" consists of 16 modules based on cognitive behavioral therapy, acceptance and commitment therapy and mindfulness-based stress reduction. Differences in distress between the baseline (T0), post-intervention (T1), and follow-up (T2) were analyzed using an ANCOVA and post-hoc <i>t</i>-tests. Secondary outcomes (anxiety, depression, mindfulness, and self-efficacy) were also compared between measuring points, using ANOVAs and post-hoc tests.</p><p><strong>Results: </strong>A significant reduction (<i>p</i><sub>adj</sub> = 0.014, <i>d</i> = 0.654) in distress from baseline (T0, <i>M</i> = 52.68, SD = 16.34) to follow-up (T2, <i>M</i> = 43.84, SD = 17.59) was observed. There was a significant decrease in anxiety symptoms and a significant increase in mindfulness and self-efficacy. The user's satisfaction (<i>M</i> = 28.00, range 8-32) and the usability (<i>M</i> = 89.57, range 0-100) of the intervention were high.</p><p><strong>Conclusion: </strong>The study provides preliminary evidence that the e-psycho-oncological short-term intervention \"By your Side\" can successfully reduce the distress of cancer patients. The high dropout rate (74.7%) must be taken into account.</p><p><strong>Trial registration: </strong>German Clinical Trial Register (https://www.drks.de/search/de/trial/DRKS00036001), DRKS number: 00036001 (retrospectively registered).</p>","PeriodicalId":13734,"journal":{"name":"Integrative Cancer Therapies","volume":"24 ","pages":"15347354251320047"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11863238/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrative Cancer Therapies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15347354251320047","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: A large number of patients with cancer experience distress, but not all of them receive adequate psychological support. The e-psycho-oncological short-term intervention "By your Side" was developed to offer evidence-based and low-threshold support for cancer patients dealing with distress.

Methods: A longitudinal intervention pilot study was conducted from 4 March 2022 to 4 January 2023. N = 91 participants took part in the study. N = 82 completed the first module, while n = 23 successfully completed the whole intervention and were included in the final data analyses. "By your Side" consists of 16 modules based on cognitive behavioral therapy, acceptance and commitment therapy and mindfulness-based stress reduction. Differences in distress between the baseline (T0), post-intervention (T1), and follow-up (T2) were analyzed using an ANCOVA and post-hoc t-tests. Secondary outcomes (anxiety, depression, mindfulness, and self-efficacy) were also compared between measuring points, using ANOVAs and post-hoc tests.

Results: A significant reduction (padj = 0.014, d = 0.654) in distress from baseline (T0, M = 52.68, SD = 16.34) to follow-up (T2, M = 43.84, SD = 17.59) was observed. There was a significant decrease in anxiety symptoms and a significant increase in mindfulness and self-efficacy. The user's satisfaction (M = 28.00, range 8-32) and the usability (M = 89.57, range 0-100) of the intervention were high.

Conclusion: The study provides preliminary evidence that the e-psycho-oncological short-term intervention "By your Side" can successfully reduce the distress of cancer patients. The high dropout rate (74.7%) must be taken into account.

Trial registration: German Clinical Trial Register (https://www.drks.de/search/de/trial/DRKS00036001), DRKS number: 00036001 (retrospectively registered).

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估e -心理肿瘤短期干预“在你身边”减少癌症相关的痛苦:一项试点研究。
目的:大量癌症患者经历痛苦,但并不是所有患者都能得到足够的心理支持。电子心理肿瘤学短期干预“在你身边”是为癌症患者处理痛苦提供循证和低门槛支持而开发的。方法:从2022年3月4日至2023年1月4日进行纵向干预试点研究。N = 91名参与者参加了这项研究。N = 82完成了第一个模块,N = 23成功完成了整个干预,并被纳入最后的数据分析。“在你身边”由认知行为疗法、接受与承诺疗法、正念减压疗法等16个模块组成。使用ANCOVA和事后t检验分析基线(T0)、干预后(T1)和随访(T2)之间的痛苦差异。次要结局(焦虑、抑郁、正念和自我效能)也通过方差分析和事后检验在测量点之间进行比较。结果:从基线(T0, M = 52.68, SD = 16.34)到随访(T2, M = 43.84, SD = 17.59),窘迫程度显著降低(padj = 0.014, d = 0.654)。焦虑症状显著减少,正念和自我效能显著提高。用户满意度(M = 28.00,范围8 ~ 32)和可用性(M = 89.57,范围0 ~ 100)较高。结论:本研究为“在你身边”的电子心理肿瘤短期干预能够成功减轻癌症患者的痛苦提供了初步证据。必须考虑到高辍学率(74.7%)。试验注册:德国临床试验注册(https://www.drks.de/search/de/trial/DRKS00036001), DRKS号:00036001(回顾性注册)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Integrative Cancer Therapies
Integrative Cancer Therapies 医学-全科医学与补充医学
CiteScore
4.80
自引率
3.40%
发文量
78
审稿时长
>12 weeks
期刊介绍: ICT is the first journal to spearhead and focus on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. Contributors are leading oncologists, researchers, nurses, and health-care professionals.
期刊最新文献
The Efficacy and Safety of Nutritional Supplements for Cancer Supportive Care: An Umbrella Review and Hierarchical Evidence Synthesis. Modified Wen Luo Tong Alleviated Chemotherapy-Induced Peripheral Neuropathy via Regulating the CX3CL1/CX3CR1 Axis Through Inhibiting NF-κB and STAT3 Pathways. Exercise as Precision Medicine: Targeting HER2/CD44-Driven Therapy Resistance in Breast Cancer (A Mini Review). Comment on "Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics During Breast Cancer Treatment". Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1